NCT05129098

Brief Summary

Recently, the concept of physiological pacing has emerged in the clinical practice, in an attempt to prevent the deteriorating effects of right ventricular pacing in the long-term. Left bundle branch pacing seems to be a safe procedure with promising results that may prevent intraventricular dyssynchony compared with the conventional right ventricular pacing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 13, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 22, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

October 29, 2021

Last Update Submit

October 25, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Echocardiographic dyssynchrony index, as expressed with Global Left Ventricular Myocardial Work Efficiency (GWE) (%)

    Follow-up transthoracic echocardiography will be held 24 hours, 3 months, 6 months and one year after the procedure and the global left ventricular work efficiency- as a measure of dyssynchrony- will be recorded.

    24 hours after the procedure as baseline and change at 3 months, 6 months and one year post-procedure

Secondary Outcomes (20)

  • Procedure Time (min)

    1 Day of procedure

  • Fluoroscopy Time (min)

    1 Day of procedure

  • Dose Area Product (DAP) (cGy/cm2)

    1 Day of procedure

  • Implant success

    1 Day of procedure

  • Complications associated with pacemaker implantation

    through study completion at 1 year post randomisation

  • +15 more secondary outcomes

Study Arms (2)

Left Bundle Branch Pacing

EXPERIMENTAL

Implantation of a left bundle branch lead via sheath, to perform left bundle branch pacing

Device: Left bundle branch pacing lead (Select Secure 3830 lead)

Conventional Right Venticular Pacing

ACTIVE COMPARATOR

The ventricular lead will be implanted in the right ventricle in the conventional way

Device: Right ventricular active fixation lead

Interventions

Implantation of a left bundle branch pacing lead via sheath

Left Bundle Branch Pacing

Active fixation lead (standard)

Conventional Right Venticular Pacing

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\>18 years old
  • Patients with atrioventricular block and EF\>50% with a predicted ventricular pacing rate\>20%
  • Patients with intraventricular septal diameter\>8mm
  • Written informed consent

You may not qualify if:

  • Indication for CRT or ICD device
  • Patients with no subclavian approach, who are candidates for leadless devices
  • Presence of severe tricuspid regurgitation
  • Patients who are candidates for implantation from the right side, as currently the provided tools for left bundle branch pacing fascilitate only left sided pacemaker implantations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Patras

Pátrai, Rion, 26504, Greece

Location

Study Officials

  • Georgios Leventopoulos, MD, PhD

    University Hospital of Patras

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principa Investigator

Study Record Dates

First Submitted

October 29, 2021

First Posted

November 22, 2021

Study Start

July 13, 2021

Primary Completion

December 20, 2022

Study Completion

December 20, 2022

Last Updated

October 27, 2023

Record last verified: 2023-10

Locations